Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms
Restricted accessMeeting reportFirst published online December, 2009
Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms
WiesnerM., “Assessing the Risk of Manufactured Nanomaterials,”Environmental Science and Technology40, no. 14 (2006): 4336–4345; AndowD.HilbeckA., “Science-Based Risk Assessment for Non-Target Effects of Transgenic Crops,”BioScience54, no. 7 (2004): 637–649.
2.
Convention on Biological Diversity, “Frequently Asked Questions on the Biosafety Protocol,”available at <http://www.bio-div.org/biosafety/faqs.shtml?area=biotechnology&faq=2> (last visited September 11, 2009); Secretariat of the Convention on Biological Diversity, Cartagena Protocol on Biosafety to the Convention on Biological Diversity, 2000; MunsonA., “Genetically Manipulated Organisms: International Policy-Making and Implications,”International Affairs69, no. 3 (1993): 497–517.
3.
See Wiesner, supra note 1; KlaineS. J., “Nanomaterials in the Environment: Behavior, Fate, Bioavailability and Effects,”Environmental Toxicology and Chemistry27, no. 9 (2008): 1825–1851.
4.
A point-source pollutant is one that is released into the environment at a particular place and time, such as factory and sewage effluents.
5.
National Research Council (NRC), Risk Assessment in the Federal Government: Managing the Process (Washington, D.C.: National Academy Press, 1983).
U.S. Presidential/Congressional Commission on Risk Assessment and Risk Management, Framework for Environmental Health Risk Management, Final Report, vol. 1 (1997), available through <http://www.riskworld.com/Nreports/1997/risk-rpt/pdf/EPAJAN.pdf> (last visited September 11, 2009).
8.
National Research Council (NRC), Environmental Effects of Transgenic Plants (Washington, D.C.: National Academy Press, 2002).
9.
See AndowHilbeck, supra note 1; CairnsJ.Jr.MountD. I., “Aquatic Toxicology: Part 2 of a Four-Part Series,”Environmental Science and Technology24, no. 2 (1990): 154–161; ElmegaardN.JagersA., Safety Factors in Pesticide Risk Assessment, Differences in Species and Acute-Chronic Relations, Silkeborg, Denmark, National Environmental Research Institute, NERI Technical Report 325 (2000); ForbesV. E.ForbesT. L., Ecotoxicology in Theory and Practice (London: Chapman & Hall, 1994); ForbesV. E.CalowP., “Extrapolation in Ecological Risk Assessment: Balancing Pragmatism and Precaution in Chemical Controls Legislation,”BioScience52, no. 3 (2002): 249–257; StarkJ. D.BanksJ. E.VargasR., “How Risky Is Risk Assessment: The Role that Life History Strategies Play in Susceptibility of Species to Stress,”Proceedings of the National Academy of Sciences101, no. 3 (2004): 732–736; see Suter, supra note 6.
LevidowL., “Democratizing Technology – Or Technologizing Democracy? Regulating Agricultural Biotechnology in Europe,”Technology in Society20, no. 2 (1998): 211–226; WynneB., “Uncertainty and Environmental Learning: Reconceiving Science and Policy in the Preventative Paradigm,”Global Environmental Change2, no. 2 (1992): 111–127.
12.
LevidowL.CarrS.WieldD., “Genetically Modified Crops in the European Union: Regulatory Conflicts as Precautionary Opportunities,”Journal of Risk Research3, no. 3 (2000): 109–208; StirlingA., “Opening Up or Closing Down: Analysis, Participation and Power in the Social Appraisal of Technology,” in LeachM.ScoonesI.WynneB., eds., Science, Citizenship and Globalisation (London: Zed Books, 2005): At 218–231.
13.
SusskindL.LevyP. F.Thomas-LarmerJ., Negotiating Environmental Agreements: How to Avoid Escalating Confrontation, Needless Costs, And Unnecessary Litigation (Washington, D.C.: Island Press, 2000).
14.
Id.
15.
WagnerV., “The Emerging Nanomedicine Landscape,”Nature Biotechnology24, no. 10 (2006): 1211–1217; OberdorsterG.OberdorsterE.OberdorsterJ., “Nanotoxicology; An Emerging Discipline Evolving from Studying of Ultrafine Particles,”Environmental Health Perspectives113, no. 7 (2005): 823–839.
16.
Id. (Wagner).
17.
MaynardA. D., “Nanotechnology: The Next Big Thing or Much Ado About Nothing?”Annals of Occupational Hygiene51, no. 1 (2007): 1–12; KuzmaJ.VerHageP., Nanotechnology in Agriculture and Food Production: Anticipated Applications, Woodrow Wilson International Center for Scholars, Washington, D.C., September 2006.
WaltersL., “The Oversight of Human Gene Transfer Research,”Kennedy Institute of Ethics Journal10, no. 2 (2000): 171–174; ZallenD. T., “US Gene Therapy in Crisis,”Genetics & Society16, no. 6 (2000): 272–275; AbbottK. W.MarchantG. E.SylvesterD. J., “A Framework Convention for Nanotechnology?”Environmental Law Reporter36 (2006): 10931–10942.
20.
TiedjeJ. M.ColwellR. K.GrossmanY. L.HodsonR. E.LenskiR. E.MackR. M.RegalP. J., “The Planned Introduction of Genetically Engineered Organisms: Ecological Considerations and Recommendations,”Ecology70, no. 2 (1989): 298–315.
21.
ThitaiG. N. W.Mbaratha-RurigiJ.GakuruO.AmuyunzuP., Kenya Biosafety Framework, UNEP/GEF Pilot Biosafety Enabling Activity Project, National Council for Science and Technology, Nairobi, Kenya, 1999.
22.
TraynorP. L.FredrickR. J.KochM., “Biosafety and Risk Assessment,” in Agricultural Biotechnology: A Workbook for Technical Training, The Agricultural Biotechnology Support Project, Institute of International Agriculture, Michigan State University, Lansing, MI, 2002.
23.
SkorupinskiB., “Debating Risks and Hazards: About Deliberation and Deliberate Release,” in BrecklingB.VerhoevenR., eds., Risk Hazard Damage: Specification of Criteria to Assess Environmental Impact of Genetically Modified Organisms, Naturschutz und Biologische Vielfalt, vol. 1 (Bonn, Germany: Federal Agency for Nature Conservation, 2004).
24.
MillerH. I., “A Need to Reinvent Biotechnology Regulation at the EPA,”Science266, no. 5192 (1994): 1815–1818; McLeanM. A.FrederickR. J.TraynorP. L.CohenJ. I.KomenJ. A., A Conceptual Framework for Implementing Biosafety: Linking Policy, Capacity and Regulation. International Service for National Agricultural Research Briefing Paper 47 (New York: ISNAR, 2002).
25.
Modified for nanotechnology, based on the PFOA methodology presented in NelsonK. C.BankerM. J., “Problem Formulation and Option Assessment Handbook: Science-Guided MultiStakeholder Deliberation,” in Ecological Risk Assessment of Genetically Engineered Organisms, GMO-ERA Project, 2007, and applied to Bt corn in Kenya, Bt cotton in Brazil and Vietnam, and genetically engineered fish in multiple countries. The methodology was refined over time through workshops with scientists, managers, and government decision makers. See NelsonK. C.KibataG.MuhammadL.OkuroJ. O.MuyekhoF.OdindoM.ElyA.WaquilJ., “Problem Formulation and Options Assessment (PFOA) for Genetically Modified Organisms: The Kenya Case Study,” in HilbeckA.AndowD. A., eds., Environmental Risk Assessment of Genetically Modified Organisms, Vol. 1: A Case Study of Bt Maize in Kenya (Wallingford, UK: CABI Publishing, 2004): At 57–82; CapalboD. M. F.SimonM. F.NodariR. O.ValleS.dos SantosR. F.CoradinL.de O. DuarteJ.MirandaJ. E.DiasE. P. F.QuyenL. Q.UnderwoodD.NelsonK. C., “Consideration of Problem Formulation and Option Assessment for Bt Cotton In Brazil,” in HilbeckA.AndowD. A.FontesE. M. G., eds., Environmental Risk Assessment of Genetically Modified Organisms, Vol. 2: Methodologies for Assessing Bt Cotton in Brazil (Wallingford, UK: CABI Publishing, 2006): At 67–92; NelsonK. C.BasiaoZ.CooperA.DeyM.HernandezM. L.KunawasenS.LiS.FonticiellaD.RatnerB. D.ToledoM. I.LeelapatraW., “Problem Formulation and Options Assessment (PFOA): Science-Guided Deliberation in Ecological Risk Assessment of Transgenic Fish,” in KapuscinskiA.LiS.HayesK.DanaG., eds., Environmental Risk Assessment of Genetically Modified Organisms: Methodologies for Transgenic Fish (London: CABI Publications, 2007): At 29–60; NguyenV. U.PhanV. C.NguyenV. B.NhanH. T.QuyenL. Q.HongN. X.SatL. M.WalsA.CapalboD. M. F.NelsonK. C., “Consideration of Problem Formulation and Option Assessment (PFOA) for Environmental Risk Assessment: Bt cotton in Vietnam,” in AndowD.HilbeckA.TuatN. V., eds., Environmental Risk Assessment of Genetically Modified Organisms: Challenges and Opportunities with Bt Cotton in Viet Nam (London: CABI Publications, 2008): at 64–78.
26.
Id. (Nelson and Banker).
27.
The GMO ERA Project is an initiative driven by public sector scientists, which responded to the expressed need for ERA methodologies better suited for genetically modified organisms. The project worked to develop comprehensive, transparent, scientific methodologies and processes for testing, monitoring, and regulating transgenic genetically modified organisms. Information about the project is available at <http://www.gmo-era.umn.edu> (last visited September 11, 2009).
28.
See NelsonBanker, supra note 25.
29.
ParadiseJ.WolfS. M.KuzmaJ.KuzhabekovaA.KokolliE.RamachandranG., “Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences,”Journal of Law, Medicine & Ethics37, no. 4 (2009): 688–705.
30.
KuzmaJ.ParadiseJ.RamachandranG.KimJ.KokotovichA.WolfS. M., “An Integrated Approach to Oversight Assessment for Emerging Technologies,”Risk Analysis28, no. 4 (2008): 1179–1195; HarshM., “Formal and Informal Governance of Agricultural Biotechnology in Kenya: Participation and Accountability in Controversy Surrounding the Draft Biosafety Bill,”Journal of International Development17, no. 5 (2004): 661–667; see Levidow, supra note 12.
31.
National Research Council (NRC), Understanding Risk: Informing Decisions in a Democratic Society (Washington, D. C.: National Academies Press, 1996).
32.
MillsT. J.QuigleyT. M.EverestF. J., “Science-Based Natural Resource Management Decisions: What Are They?”Renewable Resources Journal19, no. 2 (2001): 10–15.
33.
See Hill, supra note 10.
34.
See Skorupinski, supra note 23; IrwinA., “Constructing the Scientific Citizen: Science and Democracy in the Biosciences,”Public Understanding of Science10, no. 1 (2001): 1–18. International Risk Governance Council, Risk Governance: Towards an Integrative Approach, White Paper No. 1, Geneva, 2005.
35.
HallermanE. M.KapuscinskiA. R., “Incorporating Risk Assessment and Risk Management into Public Policies on Genetically Modified Finfish And Shellfish,”Aquaculture137, no. 1 (1995): 9–17.
36.
PriestS., “The North American Opinion Climate for Nanotechnology and Its Products: Opportunities and Challenges,”Journal of Nanoparticle Research8, no. 5 (2006): 563–568.
37.
MaynardA. D., “Nanotechnology: Managing the Risks,”Nano Today1 (2006): 22–33; MaynardA. D.AitkenR. J.ButzT.ColvinV.DonaldsonK.OberdorsterG.PhilbertM. A.RyanJ.SeatonA.StoneV.TinkleS. S.TranL.WalkerN. J.WarheitD. B., “Safe Handling of Nanotechnology,”Nature444, no. 16 (2006): 267–269; MaynardA. D., “Nanotechnology: The Next Big Thing or Much Ado About Nothing?”Annals of Occupational Hygiene51, no. 1 (2007): 1–12.
38.
ForesterJ., The Deliberative Practitioner: Encouraging Participatory Planning Processes (Cambridge: MIT Press, 1999).
39.
Id.
40.
SusskindL.LevyP. F.Thomas-LarmerJ., Negotiating Environmental Agreements: How to Avoid Escalating Confrontation, Needless Costs, and Unnecessary Litigation (Washington, D.C.: Island Press, 2000).
41.
StirlingA., “Opening Up or Closing Down: Analysis, Participation and Power in the Social Appraisal of Technology,” in LeachM.ScoonesI.WynneB., eds., Science, Citizenship and Globalisation (London: Zed Books, 2005): At 218–231.
42.
European Food Safety Authority (EFSA), Environmental Risk Assessment of Genetically Modified Plants: Challenges and Approaches, EFSA Scientific Colloquium Summary Report 8Parma, Italy, 2008.
43.
National Research Council (NRC), Understanding Risk: Informing Decisions in a Democratic Society (Washington, D.C.: National Academies Press, 1996).
44.
SagarA.DaemmrichA.AshiyaM., “The Tragedy of the Commoners: Biotechnology and Its Publics,”Nature Biotechnology18, no. 1 (2000): 2–4.
45.
See KuzmaJ.NajmaieP.LarsonJ., “Evaluating Oversight Systems for Emerging Technologies: A Case Study of Genetically Engineered Organisms,”Journal of Law, Medicine & Ethics37, no. 4 (2009): 546–586; ParadiseJ., “Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology,”Journal of Law, Medicine & Ethics37, no. 4 (2009): 688–705; Young ChoiJ.RamachandranG., “Review of the OSHA Framework for Oversight of Occupational Environments,”Journal of Law, Medicine & Ethics37, no. 4 (2009): 633–650; and WolfS. M.GuptaR.KohlheppP., “Gene Therapy Oversight: Lessons for Nanobiotechnology,”Journal of Law, Medicine & Ethics37, no. 4 (2009): 659–684.
46.
BinghamL. B.NabatchiT.O'LearyR., “The New Governance: Practices and Processes for Stakeholder and Citizen Participation in the Work of Government,”Public Administration Review65, no. 5 (2005): 547–558; HemmatiM., MultiStakeholder Processes for Governance and Sustainability: Beyond the Deadlock and Conflict (London: Earthscan Publications Inc., 2002).
47.
See supra note 44.
48.
See Susskind, supra note 13.
49.
Id.
50.
BinghamL. B.NabatchiT.O'LearyR., “The New Governance: Practices and Processes for Stakeholder and Citizen Participation in the Work of Government,”Public Administration Review65, no. 5 (2005): 547–558.
51.
O'BrienM., Making Better Environmental Decisions: An Alternative to Risk Assessment, 3rd ed. (Cambridge: MIT Press, 2000).
52.
WondolleckJ. M.YaffeeS. L., Making Collaboration Work: Lessons from Innovation in Natural Resource Management (Washington, D.C.: Island Press, 2000).
53.
Id.
54.
GloverD.KeeleyJ.McGeeR.NewellP.Da CostaP.OrtegaA. R.LoureiroM.LinL. L., Public Participation in National Biosafety Frameworks: A Report for UNEP-GEF and DFID, Institute of Development Studies, Brighton, U.K., 2003.
55.
See Bingham, supra note 49.
56.
UNEP-GEF, Report of the Subregional Workshops for Asian Countries on: Risk Assessment and Management and Public Awareness and Participation, UNEP-GEF Project on Development of National Biosafety Frameworks, Asian Countries Subregional Workshop, January 21–24, 2003, Kuala Lumpur, Malaysia, UNEP-GEF Biosafety Unit, Geneva, 2003; UNEP- GEF, Sub-Regional Workshop for Latin American Countries on: Development of a Regulatory Regime and Administrative Systems, UNEP-GEF Project on Development of National Biosafety Frameworks, Latin American Sub-Regional Workshop on Development of a Regulatory Regime and Administrative Systems, November 25–28, 2003, Santiago, Chile, UNEP-GEF Biosafety Unit, Geneva, 2003.
57.
MacoubrieJ., Informed Public Perceptions of Nanotechnology and Trust in Government, Woodrow Wilson International Center for Scholars, Washington, D.C., 2005.
58.
See NelsonBanker, supra note 25.
59.
HilbeckA.AndowD. A., eds., Environmental Risk Assessment of Genetically Modified Organisms, Vol. 1: A Case Study of Bt Maize in Kenya (Wallingford, U.K.: CABI Publishing, 2004); HilbeckA.AndowD. A.FontesE. M. G., eds., Environmental Risk Assessment of Genetically Modified Organisms, Vol. 2: Methodologies for Assessing Bt Cotton in Brazil (Wallingford, U.K.: CABI Publishing, 2006); AndowD. A.TuatN. V.HilbeckA., eds., Environmental Risk Assessment of Genetically Modified Organisms, Vol. 4: Challenges and Opportunities with Bt Cotton in Vietnam (Wallingford, U.K.: CABI Publishing, 2008).